Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Medico-economic Evaluation Comparing the Impact of the New Fixed-dose Nivolumab Regimen With the Old mg/kg Regimen in the Management of Patients With Metastatic Cancer

NCT05380336 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT05380336
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05380336 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Medico-economic Evaluation Comparing the Impact of the New Fixed-dose Nivolumab Regimen With the Old mg/kg Regimen in the Management of Patients With Metastatic Cancer
Lead sponsor
Nantes University Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2014
Completion date
December 31, 2021
Enrollment
40,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cancer